A phase I/II study of radiation therapy, paclitaxel poliglumex and cetuximab in advanced head and neck cancer.
Phase of Trial: Phase I/II
Latest Information Update: 03 Mar 2017
At a glance
- Drugs Cetuximab; Paclitaxel poliglumex
- Indications Head and neck cancer
- Focus Adverse reactions; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 22 Mar 2015 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov.
- 22 Mar 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov.